{"disease":{"id":"cs","name":"cs"},"drugs":{"marketed":[{"drug_id":"darolutamide","indication_name":"Metastatic castration-sensitive prostate cancer (mCSPC) with docetaxel","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nubeqa","generic_name":"darolutamide","company_name":"Bayer","drug_phase":"marketed","molecular_target":"androgen receptor (AR)","drug_class":"","quality_score":76,"revenue":"1600","mechanism":"Darolutamide inhibits androgen receptor activity, reducing prostate cancer cell growth and tumor size."},{"drug_id":"darolutamide","indication_name":"Metastatic castration-sensitive prostate cancer (mCSPC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nubeqa","generic_name":"darolutamide","company_name":"Bayer","drug_phase":"marketed","molecular_target":"androgen receptor (AR)","drug_class":"","quality_score":76,"revenue":"1600","mechanism":"Darolutamide inhibits androgen receptor activity, reducing prostate cancer cell growth and tumor size."},{"drug_id":"abrocitinib-100-mg","indication_name":"Moderate to severe atopic dermatitis in adults who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abrocitinib 100 mg","generic_name":"abrocitinib-100-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"JAK1","drug_class":"Janus kinase inhibitor","quality_score":48,"revenue":"284","mechanism":""},{"drug_id":"abrocitinib-100-mg","indication_name":"Moderate to severe atopic dermatitis in children aged 12 years and older who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abrocitinib 100 mg","generic_name":"abrocitinib-100-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"JAK1","drug_class":"Janus kinase inhibitor","quality_score":48,"revenue":"284","mechanism":""},{"drug_id":"abrocitinib-200-mg","indication_name":"Moderate to severe atopic dermatitis in adults who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abrocitinib 200 mg","generic_name":"abrocitinib-200-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"JAK1","drug_class":"JAK inhibitor","quality_score":40,"revenue":"284","mechanism":""},{"drug_id":"cosibelimab","indication_name":"metastatic cutaneous squamous cell carcinoma (mCSCC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Unloxcyt","generic_name":"COSIBELIMAB","company_name":"Checkpoint Therapeutics Inc","drug_phase":"marketed","molecular_target":"Pd-1","drug_class":"Programmed Death Ligand-1 Blocker [EPC]","quality_score":10,"revenue":null,"mechanism":"Unloxcyt blocks the PD-1/PD-L1 pathway to help the immune system recognize and attack cancer cells."},{"drug_id":"cosibelimab","indication_name":"locally advanced CSCC (laCSCC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Unloxcyt","generic_name":"COSIBELIMAB","company_name":"Checkpoint Therapeutics Inc","drug_phase":"marketed","molecular_target":"Pd-1","drug_class":"Programmed Death Ligand-1 Blocker [EPC]","quality_score":10,"revenue":null,"mechanism":"Unloxcyt blocks the PD-1/PD-L1 pathway to help the immune system recognize and attack cancer cells."},{"drug_id":"plozasiran","indication_name":"familial chylomicronemia syndrome (FCS)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Redemplo","generic_name":"PLOZASIRAN","company_name":"Arrowhead","drug_phase":"marketed","molecular_target":"apoC-III mRNA","drug_class":"APOC-III-directed RNA Interaction [EPC]","quality_score":47,"revenue":null,"mechanism":"Plozasiran reduces hepatic and serum apoC-III protein by degrading apoC-III mRNA via RNA interference, leading to increased clearance of serum triglycerides."},{"drug_id":"chembl-chembl254328","indication_name":"Metastatic high-risk castration-sensitive prostate cancer (CSPC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abiraterone Acetate","generic_name":"ABIRATERONE","company_name":"Janssen Biotech","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":42,"revenue":null,"mechanism":"Abiraterone Acetate blocks the production of androgens, which are hormones that prostate cancer cells need to grow."},{"drug_id":"oral-p2y12-receptor-blocker","indication_name":"Prevention of atherothrombotic events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Oral P2Y12 receptor blocker","company_name":"Italian Society of Invasive Cardiology","drug_phase":"marketed","molecular_target":"P2Y12 adenosine diphosphate receptor on platelet surface","drug_class":"Antiplatelet agent; P2Y12 receptor antagonist; Thienopyridine or non-thienopyridine class","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"milrinone-lactate","indication_name":"Acute decompensated heart failure in patients receiving diuretics","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Milrinone Lactate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Phosphodiesterase-3 (PDE-3) enzyme","drug_class":"Inotropic agent; Phosphodiesterase-3 inhibitor; Vasodilator","quality_score":66,"revenue":null,"mechanism":"Phosphodiesterase-3 inhibitor that increases cardiac contractility and promotes vasodilation through cAMP elevation."},{"drug_id":"bleomycin","indication_name":"International Federation of Gynecology and Obstetrics stage finding for vulvar carcinoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Blenoxane","generic_name":"BLEOMYCIN","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"Aspartyl/asparaginyl beta-hydroxylase","drug_class":"Cytoprotective Agent","quality_score":62,"revenue":null,"mechanism":"Bleomycin works by binding to DNA and causing strand breaks, which ultimately leads to cell death."},{"drug_id":"haloperidol","indication_name":"Control of Tics and Vocal Utterances in Tourette's Disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Haldol","generic_name":"haloperidol","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"Typical Antipsychotic [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"chembl-chembl941","indication_name":"Newly Diagnosed Ph+ ALL in Pediatrics","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"IMATINIB","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":12,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl1094636","indication_name":"BRCA2-mutated mCSPC","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NIRAPARIB","company_name":"","drug_phase":"marketed","molecular_target":"PARP-1, PARP-2, CYP17","drug_class":"","quality_score":48,"revenue":null,"mechanism":"Niraparib inhibits PARP enzymes, causing DNA damage and cell death, while abiraterone inhibits CYP17, reducing androgen production."},{"drug_id":"potassium-bicarbonate","indication_name":"Prevention of Potassium Depletion - Digitalis and Diuretics","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"POTASSIUM BICARBONATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":14,"revenue":null,"mechanism":null}],"pipeline":[{"drug_id":"lutetium-177","indication_name":"Metastatic Castration Sensitive Prostate Cancer (mCSPC)","indication_type":"pipeline","phase":"preclinical","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lutetium-177","generic_name":"lutetium-177","company_name":"Pfizer Inc.","drug_phase":"preclinical","molecular_target":"","drug_class":"mCRPC","quality_score":null,"revenue":null,"mechanism":"mCRPC"}],"offLabel":[],"totalMarketed":16,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT06057181","title":"Helix Research Network","phase":"","overall_status":"RECRUITING","enrollment_count":2000000,"lead_sponsor_name":"Helix, Inc","has_results":false},{"nct_id":"NCT05137977","title":"Is Invasive ICU-treatment Associated With Mental Illness?","phase":"","overall_status":"COMPLETED","enrollment_count":1048576,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT06272942","title":"An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":640058,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03151616","title":"Anticholinergic Risk Scale and Resource Use After Elective Noncardiac Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":244976,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":true},{"nct_id":"NCT06951061","title":"Reproductive Outcomes After Intracytoplasmic Sperm Injection (ICSI) With Surgically Retrieved Sperm.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04504162","title":"Monitoring and Risk Prediction of Iatrogenic Sedative Hypnotics Addiction in a Shanghai Psychiatric Hospital","phase":"","overall_status":"UNKNOWN","enrollment_count":100000,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT06454019","title":"Phone Outreach Nudges Among Individuals Losing Medicaid Coverage","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":60045,"lead_sponsor_name":"Covered California","has_results":false},{"nct_id":"NCT06894095","title":"Dongzong Cardiovascular Bio-imaging Registry Study","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Jinling Hospital, China","has_results":false},{"nct_id":"NCT06547281","title":"Machine Learning Prediction of Multiple Infections in Elderly Surgical Patients","phase":"","overall_status":"COMPLETED","enrollment_count":42540,"lead_sponsor_name":"Weidong Mi","has_results":false},{"nct_id":"NCT06612177","title":"Elderly Patients Surgical Site Infection Phenotypes Identification","phase":"","overall_status":"COMPLETED","enrollment_count":42532,"lead_sponsor_name":"Weidong Mi","has_results":false},{"nct_id":"NCT06265493","title":"Postoperative Infectious Complications Calculator for Elderly Patients","phase":"","overall_status":"COMPLETED","enrollment_count":37230,"lead_sponsor_name":"Weidong Mi","has_results":false},{"nct_id":"NCT03760302","title":"Analgesia in ÖAMTC Helicopter Emergency Service in Austria","phase":"","overall_status":"COMPLETED","enrollment_count":35000,"lead_sponsor_name":"Medical University Innsbruck","has_results":false},{"nct_id":"NCT05065931","title":"Real-world Effectiveness Evaluation of Clinical Decision Support System Based on Artificial Intelligence (AI-CDSS)","phase":"","overall_status":"COMPLETED","enrollment_count":34113,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT04105036","title":"Social Deprivation Assessment in Older Adults","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Jewish General Hospital","has_results":false},{"nct_id":"NCT03679221","title":"Motoric Cognitive Risk and Depression","phase":"","overall_status":"UNKNOWN","enrollment_count":30000,"lead_sponsor_name":"Jewish General Hospital","has_results":false},{"nct_id":"NCT07031921","title":"Ultrasound Image Bank: Advancing Medical Research and Diagnostics","phase":"","overall_status":"RECRUITING","enrollment_count":25000,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05791630","title":"The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL)","phase":"NA","overall_status":"RECRUITING","enrollment_count":23650,"lead_sponsor_name":"Ostfold Hospital Trust","has_results":false},{"nct_id":"NCT03180060","title":"Meta-Analysis of Stress Myocardial Perfusion Imaging","phase":"","overall_status":"COMPLETED","enrollment_count":23051,"lead_sponsor_name":"American British Cowdray Medical Center","has_results":false},{"nct_id":"NCT06092658","title":"Cohort Study of Chronic Heart Failure","phase":"","overall_status":"COMPLETED","enrollment_count":20000,"lead_sponsor_name":"Xiang Xie","has_results":false},{"nct_id":"NCT04145388","title":"Family History Study on Cancer Risk","phase":"NA","overall_status":"UNKNOWN","enrollment_count":18623,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT04377581","title":"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior","phase":"","overall_status":"COMPLETED","enrollment_count":18251,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false},{"nct_id":"NCT04574895","title":"Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events","phase":"NA","overall_status":"COMPLETED","enrollment_count":17427,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT00339508","title":"Exploratory Data Analysis for Disease Pedigrees and Cancer Genetics","phase":"","overall_status":"COMPLETED","enrollment_count":13385,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT05857735","title":"Kuwait Heart Foundation Registry of Acute Coronary Events","phase":"","overall_status":"COMPLETED","enrollment_count":10812,"lead_sponsor_name":"Gulf Heart Association","has_results":false},{"nct_id":"NCT04002258","title":"Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":10363,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT04183023","title":"Population Genomic Diversity of France","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10250,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT03871140","title":"Utility of Ultrasound Imaging for Diagnosis of Focal Liver Lesions: A Radiomics Analysis","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT07096973","title":"Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Hochgebirgsklinik Davos","has_results":false},{"nct_id":"NCT04011761","title":"Effects of Expert Arbitration on Clinical Outcomes When Disputes Over Diagnosis Arise Between Physicians and Their Artificial Intelligence Counterparts: a Randomized, Multicenter Trial in Pediatric Outpatients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Guangzhou Women and Children's Medical Center","has_results":false},{"nct_id":"NCT07515807","title":"Qatar Cardiometabolic Retrospective Cohort-Analysis Using Artificial Intelligence","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Weill Cornell Medical College in Qatar","has_results":false},{"nct_id":"NCT06481644","title":"Asia Pediatric Intensive Care Epidemiology and Outcomes Study","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"KK Women's and Children's Hospital","has_results":false},{"nct_id":"NCT03967457","title":"Comprehensive Study on the Quality of Life in Cervical Cancer Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT05061407","title":"An African, Multi-centre Evaluation of Patient Care and Clinical Outcomes for Paediatric Patients Undergoing Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":8625,"lead_sponsor_name":"University of KwaZulu","has_results":false},{"nct_id":"NCT03105713","title":"Development and Implementation of Patient Safety Checklists Before, During and After In-hospital Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":8559,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT07200648","title":"Basic Income Guaranteed: Los Angeles Economic Assistance Pilot","phase":"NA","overall_status":"COMPLETED","enrollment_count":8194,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03431142","title":"Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":7758,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT07431190","title":"British Columbia Prescriber Feedback Program - Antimicrobial Resistance","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":7626,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT04902391","title":"A Patient-Partnered, Pan-Canadian, Comparative Effectiveness Evaluation of an Acute Pediatric Mental Health and Addiction Care Bundle","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6800,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT07259252","title":"Influenza Vaccination After Acute Coronary Syndrome","phase":"NA","overall_status":"RECRUITING","enrollment_count":6620,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT07259629","title":"Fasting Induced Hypoglycaemia in Anaesthetised Paediatric Patients","phase":"","overall_status":"RECRUITING","enrollment_count":6580,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT04304118","title":"Rajaie Cardiomyopathy and Myocarditis Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"Rajaie Cardiovascular Medical and Research Center","has_results":false},{"nct_id":"NCT04492085","title":"National Survey of Workplace Violence","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT03363061","title":"Patients on Antithrombotics for Colonoscopy","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT04491201","title":"National Survey of the Impact of COVID-19 Pandemics","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT02849977","title":"Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers","phase":"","overall_status":"COMPLETED","enrollment_count":5966,"lead_sponsor_name":"Rhythm Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04263779","title":"Repisodic & Skilled Nursing Facility Preferred Provider Networks","phase":"NA","overall_status":"COMPLETED","enrollment_count":5581,"lead_sponsor_name":"Geisinger Clinic","has_results":false},{"nct_id":"NCT03810300","title":"Sustainability of Impacts of Cash Transfers, Food Transfers, and Behavior Change Communication in Bangladesh","phase":"NA","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"International Food Policy Research Institute","has_results":false},{"nct_id":"NCT04966390","title":"Standardized Clinical Application of Antibacterial/Anitifungal Drugs","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT07283809","title":"European Unified Registries for Heart Care Evaluation and Randomised Trials Italy","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Heart Care Foundation","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}